Drugs schizophrenia

Embed Size (px)

Citation preview

  • 7/28/2019 Drugs schizophrenia

    1/15

    Pharmacology

  • 7/28/2019 Drugs schizophrenia

    2/15

    Antipsychotics

    1. Typical Antipsychotics

    Dopamine antagonists

    2. Atypical Antipsychotics

    5-hydroxytryptamine effect, also effect

    dopamine

    3. Combination Drugs

  • 7/28/2019 Drugs schizophrenia

    3/15

    Typical Antipsychotics

    Tend to produce Extrapyramidal side effects:

    Parkinsonism tremors, rigidity, slowness of

    movement, temporary paralysis

    Dystonia involuntary muscle contractions

    Akathisia inability to resist urge to move

    Tardive dyskinesia involuntary movements of the

    mouth, lips, and tongue Chewing, puckering, grimacing, etc

  • 7/28/2019 Drugs schizophrenia

    4/15

    Common Typical:

    Haloperidol

    Fluphenazine

    Chlorpromazine

    Common Atypical:

    Clozapine

    Risperidone

    Olanzapine

    Ziprasidone

  • 7/28/2019 Drugs schizophrenia

    5/15

    Typical - Phenothiazines

    Dopamine D2 receptor antagonists

    Chlorpromazine- first developed from

    promethazine, first tricyclic antihistamine

  • 7/28/2019 Drugs schizophrenia

    6/15

    Typical- Haloperidol

    Butyrophenone class

    Used in 1970s almost exclusively

    Treatment of acute psychotic states More active against positive psychotic

    symptoms (delusions, hallucinations, etc)

    No anticholinergic effects therefore used inpatients with delirium

  • 7/28/2019 Drugs schizophrenia

    7/15

    Atypical Antipsychotics

    Atypicals do not induce EPSE

    Block D2 receptors and seratonin receptors

    (decreases EPSE)

    As opposed to typicals, these are more loosely

    bound to D2 receptors

    Easier dissociation

    Shown that higher occupation of D2 receptors by

    drug, higher incidence of EPSE

  • 7/28/2019 Drugs schizophrenia

    8/15

    Improve the negative symptoms and

    disorganization

    Fewer EPS side effects

    But can cause agranulocytosis so blood

    monitoring is required

  • 7/28/2019 Drugs schizophrenia

    9/15

    Clozapine

    First atypical (1990)

    Most dangerous atypical: risk ofagranulocytosis (severe decrease in WBC

    count) Most effective in reducing EPSE, also in

    reducing negative symptoms

    Increases Fos-positive neurons in the prefrontalcortex (shown to affect negative symptoms)

  • 7/28/2019 Drugs schizophrenia

    10/15

    Risperidone

    blocks several of the receptors on nerves

    including dopamine type 2, serotonin type 2,

    and alpha 2 adrenergic receptors.

    It is believed that many psychotic illnesses are

    caused by abnormal communication among

    nerves in the brain and that by altering

    communication through neurotransmitters,risperidone can alter the psychotic state.

  • 7/28/2019 Drugs schizophrenia

    11/15

    Antipsychotics Side Effects

    Extrapyramidal symptoms

    NMS

    Tarditive dyskinesia- irreversible

    Anti-cholinergic effects (dry mouth, blurredvision, photophobia, tachycardia, constipation)

    Orthohypertension

    Sedation

    Sexual dysfunction Weight gain

    agranulocytosis

  • 7/28/2019 Drugs schizophrenia

    12/15

    Side Effects

    Typical Antipsychotics

    drowsiness,

    shaking,

    trembling,

    muscle twitches, and

    spasms.

    Typical and Atypical

    Antipsychotics

    weight gain, blurred vision,

    constipation,

    lack of sex drive, and

    dry mouth.

  • 7/28/2019 Drugs schizophrenia

    13/15

    EPS Treatment

    Likely caused by blocking the central D2

    receptors responsible for movement

    Anticholinergic therapy

    - Dipenhydramine (Benadryl)

  • 7/28/2019 Drugs schizophrenia

    14/15

    THERAPIES

  • 7/28/2019 Drugs schizophrenia

    15/15